In vitro studies of deferasirox derivatives as potential organelle-targeting traceable anti-cancer therapeutics.
Chem Commun (Camb)
; 57(46): 5678-5681, 2021 Jun 08.
Article
in En
| MEDLINE
| ID: mdl-33977921
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organelles
/
Iron Chelating Agents
/
Deferasirox
/
Lung Neoplasms
/
Antineoplastic Agents
Limits:
Humans
Language:
En
Journal:
Chem Commun (Camb)
Journal subject:
QUIMICA
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom